Bryce Point Capital’s AtriCure ATRC Stock Holding History

Bryce Point Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,760	Closed	-$512K	–	202
2024 Q4	$512K	Buy	+16,760	New	+$539K	0.15%	252

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bryce Point Capital's ATRC Position: Q1 2025 in Review

Bryce Point Capital sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 16,760 shares — an estimated $512K sold.

Bryce Point Capital first reported a position in ATRC in Q4 2024 and held it in 1 quarter. The position peaked at $512K in Q4 2024. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

Bryce Point Capital reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 16,760 AtriCure shares in Q1 2025, an estimated $512K.
Bryce Point Capital first reported a position in AtriCure in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's AtriCure position peaked at $512K in Q4 2024.
221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.